INNOVATION ARTICLES
-
Rethinking Tau Biology: The Future Of Neurodegenerative Drug Discovery
We caught up with Melissa Murray, Ph.D., and Amy Rommel, Ph.D., to discuss tau-associated neurodegenerative diseases.
-
MicroRNA Therapeutics In Metabolic Liver Disease: Context-Driven Drug Discovery
Realizing the therapeutic potential of miRNAs in liver disease requires confronting a problem the field has not fully reckoned with.
-
Viral Coinfections: Emerging Challenges In Modern Drug Discovery
Viral coinfection is a phenomenon more complex than just the concurrency or sequential infection with multiple viruses in the same host.
-
Hope For Non-Hallucinogenic Neuroplastogens
We caught up with Joseph Tucker, Ph.D., to discuss Enveric Bioscience’s focus on developing non-hallucinogenic neuroplastogenic compounds.
-
The Matchmaker Modality: Engineering Event-Driven Pharmacology With Induced Proximity
Induced proximity has evolved into a versatile platform with the potential to change drug discovery, but challenges still remain.
-
A State Of Stress: Developing Therapeutics Rooted In Cell Behavior
We caught up with Yerem Yeghiazarians, CEO of Soley Therapeutics, to discuss how capturing the complexity of disease requires going beyond a single target.
INNOVATION ARTICLES. APP NOTES, CASE STUDIES. & WHITE PAPERS
-
APAC is rapidly advancing its role in the global therapeutics landscape, fueled by faster development models. Learn how this momentum is reshaping expectations for innovation and commercialization.
-
Discover how mixed-mode chromatography enables high-yield purification of single-domain antibodies under mild conditions and why these approaches outperform traditional resins.
-
Next generation sequencing technologies and workflow automation are accelerating genomic research. Learn key differences between sequencing methods and uncover strategies to boost efficiency.
-
Choosing the right mRNA manufacturing model can define your success. Learn how to weigh control, cost, and flexibility to build a strategy that supports innovation and long-term growth.
-
Lipid nanoparticles enable precise, non-viral gene editing in T cells to achieve high HDR efficiency and viability in scalable workflows. Explore how this approach overcomes viral vector limitations.
-
Optimized membranes and channel geometry accelerate mAb purification, cutting process times while maintaining product integrity. Discover how these advancements improve scalability and sustainability.
INNOVATION SOLUTIONS
-
Achieve efficient, automated filtration for biopharmaceutical production with a system offering high throughput that is designed for ultrafiltration, diafiltration, and microfiltration.
-
Generate human-relevant data with an Organ-Chip system that combines automation, imaging, and cost efficiency for faster, more confident insights for drug development and complex biological studies.
-
With 12 independent Emulations in one consumable, Chip-Array optimizes workflows and reduces cell requirements—delivering scalable, physiologically relevant models for advanced research.
-
From cancer models to high-throughput screening, Organ-Chip platforms accelerate development, improve safety, and support regulatory compliance for next-generation therapies.
-
This advanced imaging approach uses spatial and morphological data for more detailed analysis, enabling breakthroughs in understanding cell growth, function, and interaction without usual limitations.
-
Achieve top spectral resolution with advanced optical design, quality control, and workflows. Simplify experiments while meeting your panel and fluorochrome needs for high-dimensional flow cytometry.
-
Unlock cleaner flow cytometry data with engineered fluorochromes that reduce spillover and boost resolution. Design complex panels easily across conventional and spectral systems.
-
Achieve deeper T-cell characterization with a panel designed for flexibility. Streamline multicolor panel design, see higher resolution markers, and enable intracellular cytokine detection together.